Share Email Print
cover

Proceedings Paper

The need for optical imaging in the understanding and optimization of photodynamic therapy
Author(s): Nicolas Solban; Nathaniel Sznycer-Taub; Juan Manuel Benavides; Sung Chang; Irene Georgakoudi; Tayyaba Hasan
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

Optical excitation of chemicals provides reactive excited states, which can initiate chemical reactions and can also relax via radiative photophysical processes, providing the basis for fluorescence diagnostics. The best-known example of the former is Photodynamic Therapy (PDT), which is now approved for the treatment of a number of neoplastic and non-neoplastic pathologies. Although the concept of the use of photodynamic agents in diagnostics is as old as their use in therapy, the focused development of this aspect has been relatively recent. Typically, photodynamic agents have high triplet yields and relatively long triplet lifetimes (microsecond range), which allows them to interact and destroy molecular targets near them either directly or indirectly by producing other toxic molecular species. Associated with a high triplet yield is the fortunate attribute of most PDT agents in having low but finite fluorescence quantum yields. Fluorescence from these molecules may be used not only for diagnostics of disease de novo but also for guided surgery, PDT dosimetry and therapeutic monitoring. Other uses of fluorescence in PDT (not necessarily from the PDT agents) include the development of technologies that allow tracking of cells during treatment in vivo, studies of sub-cellular localization of molecules for mechanistic studies and photosensitizer tracking for specific targeting. An overview of studies on these aspects from different laboratories will be presented.

Paper Details

Date Published: 4 April 2005
PDF: 9 pages
Proc. SPIE 5704, Genetically Engineered and Optical Probes for Biomedical Applications III, (4 April 2005); doi: 10.1117/12.604768
Show Author Affiliations
Nicolas Solban, Wellman Ctr. for Photomedicine, Massachusetts General Hospital, and Harvard Medical School (United States)
Nathaniel Sznycer-Taub, Wellman Ctr. for Photomedicine, Massachusetts General Hospital, and Harvard Medical School (United States)
Juan Manuel Benavides, Wellman Ctr. for Photomedicine, Massachusetts General Hospital, and Harvard Medical School (United States)
Sung Chang, Wellman Ctr. for Photomedicine, Massachusetts General Hospital, and Harvard Medical School (United States)
Irene Georgakoudi, Wellman Ctr. for Photomedicine, Massachusetts General Hospital, and Harvard Medical School (United States)
Tayyaba Hasan, Wellman Ctr. for Photomedicine, Massachusetts General Hospital, and Harvard Medical School (United States)


Published in SPIE Proceedings Vol. 5704:
Genetically Engineered and Optical Probes for Biomedical Applications III
Darryl J. Bornhop; Samuel I. Achilefu; Ramesh Raghavachari; Alexander P. Savitsky, Editor(s)

© SPIE. Terms of Use
Back to Top